Social
Important work by Dr. Winthrop on influenza AEs in Tofacinitib patients - similar among 5mg/10mg BID, only 2 deaths/~500 cases, both with H1N1 and co-morbid RFs. Abst#L04 @RheumNow #ACR20 https://t.co/7MZYGv8W3i
Eric Dein @ejdein1 ( View Tweet )
4 years 6 months ago
Do you have a problem with no-shows? #ABS1584 discusses telemedicine and care access during COVID-19. Case Western observed a 0% cancellation rate, <10% no-show rate, & 90% of scheduled telemed visits completed during COVID-19. #ACR20 #ACRbest @RheumNow https://t.co/uxzpfELDBG https://t.co/U2qrOTJZOq
Dr. Rachel Tate @uptoTate ( View Tweet )
4 years 6 months ago
Abst#L01. Pt is on MTX/ADA for RA and asks you about their COVID risk. What do you counsel your patient? #ACR20 @RheumNow.
Eric Dein @ejdein1 ( View Tweet )
4 years 6 months ago
I just reviewed the #ACR20 talk regarding vaccination. Highly recommended/timely given data released from Pfizer today regarding the COVID-19 vaccine trial. @RheumNow
Pfizer’s Early Data Shows Vaccine Is More Than 90% Effective - The New York Times https://t.co/Fb5ZepCBeJ
Dr. Rachel Tate @uptoTate ( View Tweet )
4 years 6 months ago
Dr. Bermas presented #GRA data on 14 rheumatic Pregnant women w/ COVID-19 w/ good outcomes (4 hospitalized & no deaths) but MMWR just reported preg COVID may have worse outcomes. https://t.co/6SD6Rzbxwx https://t.co/C4QS23axfN
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 6 months ago
The @rheum_covid experience with patients with rheumatic disease who are *pregnant* and get COVID-19 is being presented by Bonnie Bermas from UTSouthwestern #ACR20 Sunday 3pm Eastern https://t.co/eeKqMXgpFx
Dr Philip Robinson @philipcrobinson ( View Tweet )
4 years 6 months ago
A Convergence of Ideas: COVID19 and ACR by Dr. Kathryn Dao (@KDAO2011)
#ACR20
https://t.co/0Rxv9GjOkw https://t.co/2uOiOZfSfM
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 6 months ago
@RetamozoSole @RheumNow @Reumaclinic @MAS_Clinic @hospitalclinic #ACR20 Thanks for sharing! but our data show that patients under anti-Cytokine therapy in monotherapy at baseline (specifically anti-IL6 -IL12/23 and -IL17) or under JAKinh were ⬇️LESS likely to be admitted (OR 0.15; 95% CI 0.03-0.66; p=0.012)
📍Limitations: small number of pts https://t.co/zeLzrNLeDQ
Juan Camilo Sarmiento-Monroy @jcsam25 ( View Tweet )
4 years 6 months ago
Awesome #COVID19 vaccine round table tonight at #ACR20 @LCalabreseDO @ACRheum @HealioRheum @RheumNow https://t.co/a6jwDHc95v
Cassandra Calabrese @CCalabreseDO ( View Tweet )
4 years 6 months ago
Dan Barouch: The #COVID19 has advantage of known spike protein which is a natural target for vaccination. HIV by contrast does not have such an obvious target. #ACR20 @RheumNow
Eric Dein @ejdein1 ( View Tweet )
4 years 6 months ago
